Background: Protein tyrosine kinases play an important role in cellular metabolism as key components of signal transduction pathways. They are involved in cellular growth, differentiation, and development. Receptor tyrosine kinases (EGF receptor and c-erbB2) have been shown to be important in the pathogenesis of cancer. In ovarian cancer, overexpression of c-erbB2, a type I receptor, has been correlated with an adverse effect on survival of patients. Material and Methods: An unusual receptor tyrosine kinase, H-RYK, has been isolated from a complimentary DNA library of SKOV-3, an epithelial ovarian cancer cell line, using a polymerase chain reaction-mediated approach. Results: The primary structure of the predicted amino acid sequence of the protein shows a novel NH2-terminal region. The catalytic region shows homology to other tyrosine kinases, the closest homology being with v-sea (39%). A significant alteration in the catalytic domain is that the highly conserved "DFG" triplet in subdomain VII is altered to "DNA." The gene was mapped to chro-
INTRODUCTION
Protein tyrosine kinases (PTK) represent a large family of enzymes that share a common highly conserved catalytic domain responsible for signal the specificity of the ligand they bind to, which can be used to subdivide them into different families (3) . The downstream signaling pathways have been defined to occur through association with src homology 2 (SH2) domain containing proteins, via ras and the MAP kinases, and also through the STAT kinase pathway, to ultimately stimulate transcription (4) (5) (6) (7) . Deregulation in any component of this pathway at the level of receptor or downstream elements has been shown to be important in malignant transformation (8) . At the level of receptors for example, overexpression of RTKs of the type I class, like EGF and c-erbB2, have been implicated in the pathogenesis of human breast and ovarian cancer (9) . Insulin-like growth factor-1 (IGF-1) receptor expression has been shown to be essential for maintenance of the transformed phenotype (10) . Recently, "ret", another class of RTK, has been shown to be important in the pathogenesis of multiple endocrine neoplasia due to mutations in the catalytic domain which alter substrate specificity (11) (12) (13) . Mutations in the fibroblast growth factor receptor family also cause human disease, such as achondroplasia (14) . Thus, RTKs have been shown to be important in the pathogenesis of cancer and other diseases.
Recently, several approaches have been employed to isolate novel receptor tyrosine kinases. The most successful approach has been that based on using the polymerase chain reaction (PCR) and degenerate oligonucleotide primers corresponding to the conserved amino acid motifs within the kinase domain (2, 15) . This has led to the isolation of several new tyrosine kinases of receptor and nonreceptor types. Adopting a similar strategy, two RTKs, EDDR1 (16) and H-RYK, were identified from an epithelial ovarian cancer cell line, SKOV-3. This paper reports the isolation, expression, and biochemical characterization of H-RYK. During the course of this investigation, an identical human cDNA was published, and hence we have chosen to use the same name, H-RYK (17, 18) . This represents a new class of receptor tyrosine kinases, with unusual sequence alterations in conserved motifs within the catalytic domain. The expression of H-RYK is localized to epithelial and stromal cells and is increased in malignant ovarian tumors. It codes for a 100-kD protein, which is expressed ubiquitously, but does not autophosphorylate in an in vitro kinase assay.
MATERIALS AND METHODS
Isolation of cDNA Clones and Sequencing RTK 15 was isolated from the SKOV-3 cDNA library as previously described (16 Chromosomal Localization Metaphase spreads were examined from PHAstimulated normal human lymphocytes using standard cytogenetic techniques (23) . The entire clone 15.5BX3 was used as a probe for fluorescent in situ hybridization (FISH) as described (24) .
Cell Lines Human cell lines were grown at 37°C in a humidified atmosphere of 5% carbon dioxide and maintained in DMEM and 10% FCS with the following supplements: 10 mM glutamine, 100 units/ml penicillin, and 12.5 [kg/ml streptomycin. The ovarian cancer cell lines SKOV-3, PEO1, PEO4, PEO14, 41M, 59M, OAW28, OAW42, and UC101 have been described previously (16) . K562, HSB2, U937, Daudi, HL60, HeLa, C6, 293, BRL, and NIH3T3 were obtained from Cell Production Services at ICRF.
RESULTS
Isolation of H-RYK cDNA Clones A short PCR fragment of 210 bp (RTK 15) was identified from a SKOV-3 cDNA library, using techniques described previously (16) . Sequencing of this fragment showed a novel sequence unrelated to previous kinases. This was used as a probe, and two clones 15SC (2.3 kb) and 15PI (2.1 kb) were identified. Sequencing of 1 5SC showed that it contained a continuous open reading frame. There was variation in the 3' region due to the presence of longer untranslated sequences in 15PI. The clones were identical in sequence in the coding region except for an inframe 9-bp insertion in 1 5.5BX3 between nucleotides 868 and 876 resulting in the addition of three amino acids, ser-leu-gly. Comparison of our sequence with that of the earlier published sequence (17, 18) showed that they were identical except for some individual amino acid differences. The entire nucleotide and the putative amino acid sequence have been deposited with the EMBL database. Organization of H-RYK Protein The predicted amino acid sequence of the putative H-RYK protein has all the features suggestive of a transmembrane receptor. This includes an extracellular domain, transmembrane domain and a conserved catalytic domain. The N-terminal domain is novel and short compared with other kinases and has at least five glycosylation sites. There is also a stretch of four basic amino acid residues KRRK (amino acid 159-162) which probably represents a potential proteolytic cleavage site as found in the insulin receptor (25) . The catalytic domain is about 39% identical to the v-sea oncogene, but the rest of the protein is dissimilar (26) . The carboxy-terminal region is only 19 amino acids long and short compared with other kinases. The critical changes in the catalytic domain compared with other kinases are shown in Fig. 1 . There are several tyrosine residues which are potential phosphorylation sites within the juxtamembrane and the catalytic domain. It is now possible to predict possible sites for binding to SH2 domain containing proteins based on the three amino acid sequences carboxy-terminal to the tyrosine (13, 27, 28 (Fig. 2) . In contrast to the earlier report (17) , no signals were identified on chromosome 17. Expression of H-RYK The clone 15SC was hybridized to poly(A)+RNA from a panel of normal tissues and detected a single 3.0-kb transcript (Fig. 3) all the cell lines compared with a GAPDH control, without significant variation (data not shown).
In Situ Hybridization to Normal Tissues In order to assess the localization of H-RYK mRNA, in situ hybridization was performed on a panel of adult and fetal human tissues. In the colon, there was a low intensity of signal in the stroma (Fig. 4 a and b) . Surface epithelium also showed some expression. In the breast, the signal was primarily localized to mammary epithelium (Fig. 4c) . In the lung (fetal) the mRNA signal was observed in the epithelium of devel- oping alveoli. It was also present in lower intensity in the cuff of smooth muscles and epithelium of larger airways (Fig. 4d) . H-RYK mRNA localized to the outer cortical layers of the fetal brain, with lesser amounts within the inner layers (Fig. 4e) . In the fetal kidney, a high level of expression was observed in the neogenic zone of the cortex, but declined rapidly in the medulla (Fig. 4f) (Fig. 5a) . In borderline tumors of the ovary, the stromal expression was again more obvious than epithelial expression (Fig. 5b) . In contrast, in malignant epithelial tumors, the mRNA levels were markedly increased compared to benign or borderline tumors (Fig. 5c) (Fig. 6a) . The two bands detected may represent two isoforms of H-RYK. Another protein of around 45 kD was detected by the two antibodies on longer exposure (Fig. 6b) . The H-RYK cDNA was cloned into an expression vector pcDNAI and CHO cells were transiently transfected. An identical protein of 100 kD was detected by the antisera in transfected cells, compared with the vector control transfected cells (Fig. 6c) (Fig. 1) and the novel extracellular domain. The canonical motif GxGxxG in the subdomain I of the catalytic domain is altered to QxGxxG. This glycine rich loop is important in keeping apart the "N" and "C" terminal lobes of the catalytic domain by steric interactions with the "DFG" triplet in subdomain VII which is conserved among all kinases (29) . In the latter motif in H-RYK, the critical aspartate is conserved but the phenylaline and glycine are altered to asparagine and alanine respectively giving the motif "DNA". The aspartate has been shown by in vitro mutagenesis to be important for kinase activity (30) . Glycine to alanine is a conserved substitution, whereas phenylalanine to asparagine is a significant alteration. Structural analysis of the insulin receptor suggests that sequence alterations in these conserved residues may contribute to poor conformation of the activation loop (29) . However, the lysine distal to the glycine rich loop which is implicated in ATP binding, is conserved. The tyrosine kinase residue essential for phosphorylation is present between subdomains VII and VIII. An explanation for the difficulty in demonstrating catalytic activity of the receptor may be because of one of the above sequence alterations. A receptor tyrosine kinase "klg" with an extracellular domain similar to the immunoglobulin superfamily and homology to v-sea (39%) in the catalytic domain was recently isolated. This receptor also does not demonstrate any catalytic activity, in which the "DFG" triplet has been substituted by "ALS" (31) . A detailed comparison of the kinase domains between "klg" and H-RYK failed to reveal any other significant differences.
Recently, it has been shown that peptide motifs surrounding the phosphorylated tyrosine provide unique sites for binding of SH2 domaincontaining proteins (27, 28) . tential tyrosine residues within the catalytic domain, with motifs suggestive of probable binding sites to known SH2 domain-containing proteins. Such motifs in other receptors usually occur outside the catalytic domain. This implies that the substrates for H-RYK maybe hitherto uncharacterized proteins or it may signal via an intermediate docking protein like IRS-1, as in the case of the insulin receptor (32) . It is possible now to test directly the preferred substrate in vitro, by examining possible phosphorylation sites using techniques described by Songyang (27) .
The mRNA for H-RYK is relatively abundant in skeletal muscle, though expressed in all other tissues. Unlike the mouse homolog of H-RYK (33, 34) , only one transcript of 3.0 kb was observed. At the mRNA level, no significant variation was observed in eight ovarian cancer cell lines. The splice variant encoding an extra three amino acids, serine, leucine, and glycine, is immediately NH2 terminal to a tyrosine in the juxta-membrane domain. This variant was shown to be expressed equally at the mRNA level, in a panel of ovarian cell lines. There is as yet no evidence of residues amino terminal of the phosphotyrosine being important in SH2 domain interactions. The only exception to this rule, though yet to be demonstrated in vivo is the "NPXY" motif thought to be important in internalization of the LDL receptor, where amino-terminal residues may be critical (35, 36) . Recently, it has been shown that the phosphotyrosine binding domain (PTB) , in contrast to the SH2 binding domain of SHC, binds to a phosphorylated tyrosine within the context of the "NPXY" motif. The asparagine is an important requirement for the binding of SHC (37). The two isoforms of H-RYK produced as a result of this splicing, may thus have different functions although this remains to be shown.
The expression of H-RYK in normal tissues as analyzed by in situ hybridization was unusual. In most of the tissues examined, the message was observed in epithelial cells and in the stroma. The expression in stroma, which comprises of various types of cells, suggests a role in cell-cell 
